National Research Corporation
General ticker "NRC" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $372.0M (TTM average)
National Research Corporation follows the US Stock Market performance with the rate: 40.7%.
Estimated limits based on current volatility of 1.8%: low 20.22$, high 20.97$
Factors to consider:
- Earnings expected soon, date: 2026-10-26 amc
- Company pays dividends (quarterly): last record date 2026-09-25, amount 0.16$ (Y3.18%)
- Total employees count: 357 (-3.0%) as of 2025
- US accounted for 100.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Customer concentration, Market competition, Economic downturns and volatility, Data collection failures, Cybersecurity threats
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [13.44$, 23.05$]
- 2026-12-31 to 2027-12-31 estimated range: [13.75$, 23.48$]
Financial Metrics affecting the NRC estimates:
- Positive: with PPE of 20.5 at the end of fiscal year the price was neutral
- Positive: 15.80 < Operating profit margin, % of 16.44
- Positive: 4.90 < Operating cash flow per share per price, % of 6.28
- Positive: -51.61 < Industry operating profit margin (median), % of -17.21
- Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 7.92
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
- Negative: -1.30 < Inventory ratio change, % of -0.61
- Negative: 7.04 < Shareholder equity ratio, % of 10.37 <= 12.78
- Positive: -2.60 < Investing cash flow per share per price, % of -2.54
Short-term NRC quotes
Long-term NRC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $148.58MM | $143.06MM | $137.39MM |
| Operating Expenses | $108.53MM | $107.87MM | $114.80MM |
| Operating Income | $40.05MM | $35.19MM | $22.59MM |
| Non-Operating Income | $-0.08MM | $-2.50MM | $-4.75MM |
| Interest Expense | $0.86MM | $2.60MM | $4.76MM |
| Income(Loss) | $39.96MM | $32.69MM | $17.84MM |
| Taxes | $8.99MM | $7.91MM | $6.25MM |
| Net Income(Loss)* | $30.97MM | $24.78MM | $11.60MM |
| Stockholders Equity | $48.95MM | $31.28MM | $13.99MM |
| Assets | $122.44MM | $132.54MM | $134.88MM |
| Operating Cash Flow | $38.11MM | $34.62MM | $26.45MM |
| Capital expenditure | $15.78MM | $15.45MM | $10.71MM |
| Investing Cash Flow | $-15.78MM | $-20.28MM | $-10.71MM |
| Financing Cash Flow | $-40.71MM | $-16.76MM | $-15.84MM |
| Earnings Per Share** | $1.26 | $1.04 | $0.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.